Abstract
Sarcopenia is a progressive, generalized syndrome characterized by decreased skeletal muscle content and decreased function. Patients with malignant tumors can develop sarcopenia at different stages of progression, with an incidence of 32.05%~70.40%, and the prevalence varies according to tumor type, stage, and measurement method. Compared with other types of tumors, the incidence of sarcopenia in patients with digestive tract tumors is higher, 17%~78%. In this paper, the PI3K/AKT/mTOR pathway was used to explore the mechanism of Qi Strengthening Decoction in the intervention of sarcopenia in patients with advanced esophageal cancer, in order to provide a method for the clinical treatment of sarcopenia.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
